Eyes on Alzheimer’s

September 21, 2018
Doctors of optometry have an important role to play in the prevention and early detection of the ocular and visual changes that herald the onset of Alzheimer's disease.
World Alzheimer's Day

An irreversible and progressive degenerative brain disease, Alzheimer's disease currently affects 5.7 million Americans age 65 and older with projections estimating 13.8 million affected by 2050. 

World Alzheimer's Day is Friday, Sep. 21, and doctors of optometry have an important role to play in the prevention and early detection of the ocular and visual changes that herald the onset of Alzheimer's disease.

Those with Alzheimer's live an average of eight years after symptoms manifest, but survival can range 4 to 20 years, per the Alzheimer's Association. Critically, early detection and diagnosis can allow patients and caregivers time to plan.  

Alzheimer's clues could be found using common eye scan

Optical coherence tomography (OCT), the diagnostic imaging device, uses light to produce a cross-sectional or three-dimensional image of the retina with micrometer resolution to detect retinal diseases such as macular degeneration, glaucoma and diabetic retinopathy. But beyond eye care, OCT continues to capture researchers' attention as a noninvasive way to examine central nervous system tissue for tell-tale signs of neurodegenerative diseases.

Numerous studies, including within the past year, suggest spectral domain-OCT (SD-OCT) might warrant further consideration in early detection and diagnosis of Alzheimer's disease, the sixth-leading cause of death in the United States.  

Optometry's role with Alzheimer's

Although vision changes naturally occur with age and don't always indicate a more serious condition, patients 60 years and older still should be wary of age-related eye health problems that may occur without any early symptoms. Regular, comprehensive eye examinations are critical in senior years and evolving understanding of neurological health increasingly turns to ocular health as a proxy. 

Maryke Neiberg, O.D., associate dean of academic affairs at Midwestern University Chicago College of Optometry, who previously spoke with AOA Focus on optometry's role in Alzheimer's care, says patients typically do have difficulty with near-vision in the beginning stages of Alzheimer's, including crowding, alexia and figure-ground difficulties. 

"The doctor of optometry has an important role to play in the prevention and early detection of the ocular and visual changes that herald the onset of Alzheimer's disease," Dr. Neiberg wrote in a continuing education article for the California Optometric Association. "We have an even more critical role to play in the education of our patients and the public about the preventable risk factors that are associated with Alzheimer's disease."  

Related News

What do the experts say on genetic testing for IRDs?

Genetic testing and counseling are critical for patients with inherited retinal diseases (IRDs). A new AOA resource offers insights into the role doctors of optometry play in considering genetic testing for IRDs, including providing in-office testing or referring to offices that do.

Pediatric keratoconus prevalence higher than believed, may change care approach

Sensitive screening in pediatric populations can help promote early diagnosis and intervention, ultimately saving vision, improving patients’ quality of life and preventing the need for corneal transplantation surgery.

Making blurry vision clear

February is Low Vision Awareness Month. Take note of considerations for enhancing success with near magnification.